"It's so ironic that CMMI, the innovation arm of CMS, is trying to sell us on implementing a new payment model for oncology while community oncology practices are struggling financially to keep their doors open because of CMS payment cuts," said Ted Okon, executive director, Community Oncology Alliance.
Cancer Patient Protection Act of 2015
Renee Ellmers
Steve Israel
The Community Oncology Alliance, a not-for-profit organization dedicated to preserving access to community cancer care, announced its vigorous support of the (H.R. 1416), a bipartisan bill introduced by Representatives (R-NC2) and (D-NY3). The bill stops the Centers for Medicare & Medicaid Services (CMS) from inappropriately applying the Medicare sequester cut to the underlying payment for cancer drugs and other Part B therapies.
The State of Cancer Care in America
Many members of Congress have expressed concerns about the detrimental effect of CMS' ill-advised cut to the payment for cancer drugs, and this is now being documented by closings of cancer clinics, consolidation into the more expensive hospital setting, and patient access problems, especially in rural areas. According to the annual report just released this week by the American Society of Clinical Oncology, , "For the more than 59 million Americans living in rural areas, a diagnosis of cancer can present unique challenges to obtaining high-quality care for their disease, including long travel distances and decreased access to specialists, and state-of-the-art diagnostics, treatments and technologies."
Read the complete press release by COA:
Varied Access: The Pharmacogenetic Testing Coverage Divide
February 18th 2025On this episode of Managed Care Cast, we speak with the author of a study published in the February 2025 issue of The American Journal of Managed Care® to uncover significant differences in coverage decisions for pharmacogenetic tests across major US health insurers.
Listen
Neurologists Share Tips for Securing Patient Access to Gene Therapies
March 19th 2025Tenacious efforts at every level, from the individual clinician to the hospital to the state to Congress, will be needed to make sure patients can access life-saving gene therapies for neuromuscular diseases.
Read More
Texas Oncology to Roll Out Canopy for ePROs After Head-to-Head Pilot
March 18th 2025Debra Patt, MD, PhD, MBA, executive vice president of Public Policy and Strategy for Texas Oncology, said the practice received positive feedback from nurses and patients during a pilot that concluded in February.
Read More
Cancer Labels on Alcohol? Ireland, Where Pubs Still Rule, Will Have Them by Next Year
March 17th 2025As St. Patrick's Day brings global celebrations involving alcohol, Ireland looks forward to rethinking excess consumption with a new tool set to arrive next year: the world's most comprehensive alcohol warning label.
Read More